Home » Authors » James Etheridge

Articles by James Etheridge

IDM To Coordinate European Project For Cancer Vaccine

Oct. 22, 2003

By James Etheridge

Neurotech Begins Clinical Work With NT-501 Product

Oct. 15, 2003

By James Etheridge

Theraptosis Enters Collaboration With Robarts Research Institute

Oct. 15, 2003

By James Etheridge

Neurotech Begins Clinical Work With NT-501 Product

Oct. 15, 2003

By James Etheridge

Theraptosis Enters Collaboration With Robarts Research Institute

Oct. 15, 2003

By James Etheridge

French Seek To Bolster Biotech Via More Public Funding In 2004

Oct. 1, 2003

By James Etheridge

Crossroads' Conference Deals With Biotech's Ethics, Issues

Oct. 1, 2003

By James Etheridge

Seeking Funds, Flamel Files For Public Offering In U.S.

Oct. 1, 2003

By James Etheridge

Seeking Funds, Flamel Files For Public Offering In U.S.

Oct. 1, 2003

By James Etheridge

Crossroads' Conference Deals With Biotech's Ethics, Issues

Oct. 1, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 17, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.